Investors Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,524
Closed -$568K 9
2021
Q4
$568K Sell
2,524
-213
-8% -$45K 0.26% 98
2021
Q3
$582K Buy
2,737
+2
+0.1% +$460 0.31% 84
2021
Q2
$667K Buy
2,735
+1
+0% +$246 0.36% 78
2021
Q1
$680K Hold
2,734
0.4% 70
2020
Q4
$629K Buy
2,734
+21
+0.8% +$4.84K 0.42% 71
2020
Q3
$690K Sell
2,713
-21
-0.8% -$5.2K 0.52% 54
2020
Q2
$645K Sell
2,734
-18
-0.7% -$4.11K 0.53% 54
2020
Q1
$558K Buy
2,752
+47
+2% +$10.3K 0.56% 55
2019
Q4
$652K Buy
+2,705
New +$596K 0.53% 55

Other funds holding AMGN

Investors Financial Group's AMGN Position: Q1 2022 in Review

Investors Financial Group sold out of Amgen (AMGN) in Q1 2022, closing a stake of 2,524 shares — an estimated $568K sold.

Investors Financial Group first reported a position in AMGN in Q4 2019 and held it in 9 quarters. The position peaked at $690K in Q3 2020. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Investors Financial Group reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Investors Financial Group sold 2,524 Amgen shares in Q1 2022, an estimated $568K.
  • Investors Financial Group first reported a position in Amgen in Q4 2019 and held it in 9 quarters.
  • Investors Financial Group's Amgen position peaked at $690K in Q3 2020.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.